cagrilintide/semaglutide Coadministered Cagrilintide and Semaglutide in Adults with Overweight or Obesity Cagrilintide & GLP-1 S |

Semaglutide, explained How and why it works Semaglutide works by mimicking a hormone pathway connected to appetite and fullness

Your titration journey completed: Month 1 0.25mg (initiation) Month 2 0.5mg (first therapeutic dose) Month 3+ 1mg (full maintenance dose) You are here Strength: 1mg | Form: Pre-Filled Syringe | Frequency: Once Weekly | Route: Subcutaneous injection Note: The 1mg dose is an initiation dose only

The typical age range spans adults from 18-65+ years, with increasing use in younger adults for obesity treatment

also reported a low risk of hypoglycemia, with events occurring in similar proportions of patients with obesity but without diabetes who were treated with liraglutide 3.0 mg (1.3%) compared with placebo (1.0%) [37]

Postprandial Study Previous to the 12-wk intervention study a postprandial study was carried out to test different doses of MO and choose one on the basis of its effects on subjects glycemia

Some women taking semaglutide have reported more regular menstrual periods